FNDC5 and metabolic disease: Irisin has been reported to improve metabolic disorders by enhancing β‐cell function and insulin secretion in diabetes.[42, 43] Our results indicate reduced body weight and decreased blood glucose in hypoxia mouse models, whereas overexpression of irisin reverses the above changes to some extent.